$AIM this is another paper by Hasegawa reviewing adjuvants and intranasal delivery. Not too much commentary on TLR9 and the end of the paper is another positive comment toward the use of Ampligen as an adjuvant. I have searched extensively for papers by Hasegawa evaluating TLR9 and cant find much of anything. He knows Ampligen, that it works and more importantly now post the Astra, J&J and LLY news it is safe. ncbi.nlm.nih.gov/pmc/articl...
  • 3
3 Likes